Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
19,746,808
-
Shares change
-
+607,032
-
Total reported value, excl. options
-
$722,803,309
-
Value change
-
+$22,868,587
-
Number of buys
-
48
-
Number of sells
-
-16
-
Price
-
$36.60
Significant Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q4 2014
77 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q4 2014.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,746,808 shares
of 62,650,155 outstanding shares and own 32% of the company stock.
Largest 10 shareholders include Third Rock Ventures, LLC (11,681,008 shares), FMR LLC (3,868,893 shares), BlackRock Fund Advisors (461,948 shares), ORBIMED ADVISORS LLC (412,335 shares), RS INVESTMENT MANAGEMENT CO LLC (354,058 shares), DEERFIELD MANAGEMENT CO (262,625 shares), ALLIANCEBERNSTEIN L.P. (249,666 shares), VANGUARD GROUP INC (222,745 shares), FEDERATED INVESTORS INC /PA/ (204,200 shares), and FRANKLIN RESOURCES INC (200,000 shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.